Intracoronary Infusion of Bone Marrow-Derived Mononuclear Cells Abrogates Adverse Left Ventricular Remodelling Post-Acute Myocardial Infarction: Insights from the Reinfusion of Enriched Progenitor Cells and Infarct Remodelling in Acute Myocardial Infarction (REPAIR-AMI) Trial

2009104 citationsJournal Article

Authors

Volker Schächinger · Goethe University Frankfurt

Birgit Aßmus · Goethe University Frankfurt

Sandra Erbs · Deutsches Herzzentrum der Charité

Albrecht Elsässer · Klinikum Oldenburg

Werner Haberbosch · Klinik für Psychosomatik

Rainer Hambrecht · Klinikum Links der Weser

Jiangtao Yu

Abstract

Intracoronary administration of BMC eliminates the correlation between depressed LVEF after reperfusion therapy and LV expansion during follow-up and, thereby, abrogates early LV remodelling after AMI.

Topics & Keywords

Acute Myocardial Infarction Research Cardiovascular Function and Risk Factors Cardiac Ischemia and Reperfusion

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: European Journal of Heart Failure

Volume 11, Issue 10, pp. 973-979

DOI: 10.1093/eurjhf/hfp113

Field-Weighted Citation Impact: 6.73